welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 278 blog entries.

Medicine Supply Notification: Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices. MSN/2024/033 Tier 2 – medium impact Date of issue: 21st March 2024 Levemir® InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices are being discontinued with remaining [...]

The post Medicine Supply Notification: Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

By |March 21st, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices

Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices MSN/2024/032 Tier 2 – medium impact Date of issue: 21st March 2024 Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued [...]

The post Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

By |March 21st, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices

MHRA Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited)

Class 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Drug alert number: EL (24)A/10 Date issued: 21 March 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Company name: Fresenius Kabi [...]

The post MHRA Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) appeared first on Community Pharmacy England.

By |March 21st, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited)

March 2024 Price Concessions 2nd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/03/2024) announced the following list of price concessions for March 2024: Drug Pack size Price concession Anastrozole 1mg tablets 28 £1.45 Azithromycin 250mg capsules 6 £4.45 Baclofen 10mg [...]

The post March 2024 Price Concessions 2nd Update appeared first on Community Pharmacy England.

By |March 20th, 2024|Lexpos News|Comments Off on March 2024 Price Concessions 2nd Update

Medicine Supply Notification: Supply issues with multiple GLP-1 RA products

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre-filled pen Dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection in a prefilled pen Liraglutide (Victoza®) 6mg/ml solution for injection in a pre-filled pen. MSN/2024/031 Tier 3 – [...]

The post Medicine Supply Notification: Supply issues with multiple GLP-1 RA products appeared first on Community Pharmacy England.

By |March 18th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Supply issues with multiple GLP-1 RA products